Literature DB >> 17485265

Neuroprotection of G-CSF in cerebral ischemia.

Chuan-Zhen Lu1, Bao-Guo Xiao.   

Abstract

In several experimental studies of cerebral ischemia, G-CSF exerts neuroprotective effects through different mechanisms, including mobilization of hematopoietic stem cells, anti-apoptosis, neuronal differentiation, angiogenesis and anti-inflammation. Hence, G-CSF not only inhibits neuron death, but also generates "new" neural tissue formation. A small pilot trial reports on the safety and feasibility of G-CSF therapy in stroke patients. According to this evidence, we can speculate that G-CSF, being used either alone or in combination with another agent, should be an effective strategy in the treatment of cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485265     DOI: 10.2741/2278

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

Review 1.  Neuroprotection through G-CSF: recent advances and future viewpoints.

Authors:  Vikrant Rahi; Sumit Jamwal; Puneet Kumar
Journal:  Pharmacol Rep       Date:  2021-01-02       Impact factor: 3.024

2.  The role of granulocyte colony-stimulating factor in the neutrophilia observed in the fetal inflammatory response syndrome.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Stanley M Berry; Sonia S Hassan; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor
Journal:  J Perinat Med       Date:  2011-07-30       Impact factor: 1.901

3.  Intranasal Delivery of Granulocyte Colony-Stimulating Factor Enhances Its Neuroprotective Effects Against Ischemic Brain Injury in Rats.

Authors:  Bao-Liang Sun; Mei-Qing He; Xiang-Yu Han; Jing-Yi Sun; Ming-Feng Yang; Hui Yuan; Cun-Dong Fan; Shuai Zhang; Lei-Lei Mao; Da-Wei Li; Zong-Yong Zhang; Cheng-Bi Zheng; Xiao-Yi Yang; Yang V Li; R Anne Stetler; Jun Chen; Feng Zhang
Journal:  Mol Neurobiol       Date:  2014-11-29       Impact factor: 5.590

4.  Ischemia/reperfusion injury promotes and granulocyte-colony stimulating factor inhibits migration of bone marrow-derived stem cells to endometrium.

Authors:  Hongling Du; Hanyia Naqvi; Hugh S Taylor
Journal:  Stem Cells Dev       Date:  2012-08-16       Impact factor: 3.272

5.  Post-MPTP treatment with granulocyte colony-stimulating factor improves nigrostriatal function in the mouse model of Parkinson's disease.

Authors:  Mark McCollum; Zhiyuan Ma; Eric Cohen; Rebecca Leon; Rui Tao; Jang-Yen Wu; Dipnarine Maharaj; Jianning Wei
Journal:  Mol Neurobiol       Date:  2010-04-21       Impact factor: 5.590

Review 6.  Neuroinflammatory basis of metabolic syndrome.

Authors:  Sudarshana Purkayastha; Dongsheng Cai
Journal:  Mol Metab       Date:  2013-10-05       Impact factor: 7.422

Review 7.  Neuroinflammation in overnutrition-induced diseases.

Authors:  Dongsheng Cai
Journal:  Vitam Horm       Date:  2013       Impact factor: 3.421

8.  Granulocyte colony-stimulating factor for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled study of Iranian patients.

Authors:  Nasibeh Amirzagar; Shahriar Nafissi; Abbas Tafakhori; Amirhossein Modabbernia; Aliakbar Amirzargar; Majid Ghaffarpour; Bahaddin Siroos; Mohammad Hossein Harirchian
Journal:  J Clin Neurol       Date:  2015-04       Impact factor: 3.077

9.  G-CSF for mobilizing transplanted bone marrow stem cells in rat model of Parkinson's disease.

Authors:  Manouchehr Safari; Behnaz Jafari; Sam Zarbakhsh; Hamidreza Sameni; Abbas Ali Vafaei; Nasrin Khan Mohammadi; Laya Ghahari
Journal:  Iran J Basic Med Sci       Date:  2016-12       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.